NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Ethermed

Ethermed

Private
Philadelphia, PennsylvaniaHealthcare & Life Scienceshttps://www.ethermed.ai/

Last Round

Series A

Apr 21, 2026

Total Funding Raised

$15M

Momentum

Top 10%

of companies Caplight tracks

Company Overview

Ethermed is a healthcare technology company that provides an AI-powered SaaS platform to automate prior authorizations. The platform integrates with EHR and payer systems to streamline workflows, reduce administrative work, and accelerate patient access to treatment.

Sector

Healthcare & Life Sciences

Verticals

Revenue Cycle, Vertical SaaS, Medical AI, Workflow Automation

Business Model

B2B

Customer Profile

Subscription SaaS, Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

prior auth automationprior authorization automationEHR integrationB2B SaaSmedical AIRCMrevenue cycle managementhealthcare automationpre-authorizationutilization managementmedical necessityworkflow automationEpic integrationCerner integrationpayer portal automationCMS compliance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Ethermed Comps

Public and private peers based on sector, stage, and business model.

Ethermed comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Ethermed Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AApr 21, 2026
SeedMar 1, 2022

Key People

Founding team and executive leadership

Daniel Friedman

CEO And Cofounder

Founding Team

John Cococcia

CFO

Executive Team

Ethermed Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 26, 2026

    Grew 15% QoQ, from 26 to 30 employees.

  • Apr 21, 2026

    $9M round closed

Ethermed Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Ethermed Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Ethermed's valuation, stock price, and market status.

Firmographic Details

HeadquartersPhiladelphia, Pennsylvania
Employee Range31
Year Founded2021
Last FundingApr 21, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.